- Report
- October 2023
- 101 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- March 2022
- 101 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- March 2022
- 105 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- August 2022
- 814 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- May 2022
- 97 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- July 2023
- 285 Pages
China
From €3867EUR$4,000USD£3,322GBP
- Report
- July 2022
- 132 Pages
Global
From €822EUR$850USD£706GBP
- Report
- February 2024
- 196 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- February 2024
- 213 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- April 2023
- 160 Pages
Global
From €5800EUR$5,999USD£4,982GBP
- Report
- February 2024
- 177 Pages
Global
From €3480EUR$3,600USD£2,990GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more